SCHEMBL13429079

SCHEMBL13429079

[C-]#[N+]c1c(N)nc(SCc2ccc(C)nc2)c(C#N)c1N1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 3/20 0.38
ALDH1A1 P00352 8/20 0.37
NPSR1 Q6W5P4 6/20 0.37
HTT P42858 4/20 0.37
TSHR P16473 3/20 0.37
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
RECQL P46063 1/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
HPGD P15428 3/20 0.36
KMT2A Q03164 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
MAPK1 P28482 3/20 0.35
TDP1 Q9NUW8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13429083 0.99 ALDH1A1 (0.39) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13456379 0.88 RET (0.44) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13429072 0.88 RET (0.39) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13429077 0.87 RET (0.38) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13456421 0.87 RET (0.43) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13429071 0.85 ALDH1A1 (0.35) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13429007 0.82 RET (0.42) RETALDH1A1NPSR1HTTTSHR
SCHEMBL13456299 0.76 RET (0.44) RETALDH1A1NPSR1HTTLMNA
SCHEMBL13429070 0.76 ADORA1 (0.47) ALDH1A1HTTADORA1KMT2AL3MBTL1
SCHEMBL13456420 0.75 RET (0.43) RETALDH1A1NPSR1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703934-B2 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-04-22 US disclosed
US-20100069363-A1 SUBSTITUTED 4-AMINO-3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069363-A1 SUBSTITUTED 4-AMINO-3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF QDPR, DDC, TPMT RET 1200/4885ALDH1A1 1558/4885NPSR1 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.